Navigation Links
Cyclosporin A Treats Leukemia Complications

Some leukemia patients with common complications of their disease may have a new way to overcome them. New research finds that chronic lymphocytic leukemia (CLL) patients with anemia or thrombocytopenia can be treated effectively with the drug, cyclosporin A. Anemia is a decrease in red cells in the blood and thrombocytopenia is when the number of platelets in reduced. The latter is the most common cause of bleeding disorders. //

At the University of Texas, M.D. Anderson Cancer Center, researchers studied 31 CLL patients who had anemia or thrombocytopenia. All patients in the study developed this complication due to an immune response to their own tissue. The patients were treated with 300 mg/day of cyclosporin A. While on the drug, more than 60 percent of the patients with thrombocytopenia had an increase in the number of platelets. Also, more than 60 percent of the patients with anemia had an increase in red blood cells in their blood. Most of the patients responded to the drug within three weeks of treatment.

Researchers conclude cyclosporin A is an effective alternative treatment for CLL patients who suffer from these blood complications. They also report the response to this drug translates into an improved tolerance of further chemotherapy treatments.


'"/>




Page: 1

Related medicine news :

1. Inhaled Cyclosporine Results In Rejection Free Survival among Lung Transplant Patients
2. Weight Reduction Surgery Also Treats Metabolic Syndrome
3. Chennai Hospital Treats Pakistani Blue Baby
4. Cocoa Treats: Chocolates, as a Health Investment? Chew on this!
5. New Gene Therapy Treats Diabetic Neuropathy
6. Actonel Treats Hip Fractures In A Better Way Than Alendronate
7. BBIC – A SOY-based Substance Treats Multiple Sclerosi
8. Cake Walk – Plum Treats Sell Like Hot Cakes During Christma
9. Common BP Drug Treats Muscular Dystrophy
10. Naltrexone also Treats Crohns Disease
11. Drug for Blood Pressure also Treats Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/27/2016)... ... May 27, 2016 , ... In response ... many who are unaware of the plight of aphasia. In collaboration with the ... “Stroke Awareness” campaign. , The link between stroke and aphasia is relatively unknown, ...
(Date:5/27/2016)... ... 27, 2016 , ... Each year Standard Process Inc. ... is this year’s Life University winner of a $2,500 scholarship from ... Leadership Awards ceremony. , Outerbridge is approaching her last quarter at Life University ...
(Date:5/26/2016)... New Hampshire (PRWEB) , ... May 26, 2016 , ... ... skin care products, has been honored with a 2016 When Work Works Award for ... prestigious award, part of the national When Work Works project administered by the Families ...
(Date:5/26/2016)... ... 26, 2016 , ... Connor Sports, through its Connor Cares initiative, ... Tamika Catchings Legacy Tour that will commemorate the Indiana Fever legend’s hall-of-fame ... in all forms and levels of the game, Connor Sports has committed to a ...
(Date:5/26/2016)... ... , ... There are nearly 14.5 million people living with and beyond cancer ... June 5, 2016, communities around the world will gather to recognize these cancer survivors ... Survivors Day® is an annual worldwide Celebration of Life that is held on the ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... SAN FRANCISCO , May 27, 2016 ... biotechnology company focused on developing products for Regenerative Medicine, Neurology and ... Commissiong will be presenting at two upcoming investor conferences: ... Conference Center, 730 Third Avenue, New York City ... at 3:00pm Marcum MicroCap Conference   ...
(Date:5/26/2016)... May 26, 2016   Change Healthcare ... analytics, network solutions and technology-enabled services designed ... entered into a strategic channel partnership with ... software solutions and revenue cycle management services ... and rehabilitation clinics to optimize revenue, operational ...
(Date:5/25/2016)... and GERMANTOWN, Maryland , May ... QGEN ; Frankfurt Prime Standard: QIA) today announced that ... with Therawis Diagnostics GmbH to develop and commercialize predictive assays ... market PITX2 as a marker to predict effectiveness of anthracycline ... "We are pleased to partner with Therawis, which ...
Breaking Medicine Technology: